庄金隆

MBChB, FHKAM (Ophth), FCOphth

• First in Hong Kong (HK) & fore-running in Asia: randomized clinical trials (RCTs) in Orbital and Oculoplastic Surgeries (OOPS), thyroid eye clinic, “medical decompression”, endoscopic navigation in orbitotomy, orbital and optic canal decompression, Mohs Micrographic Surgery and sentinel lymph node biopsy for periocular cancer, 3D-printing assisted orbital fracture repair, microrobot & flexible robots in OOPS

• Leading territory-wide in HK: Leader of a multidisciplinary team across public-private health care, both medical schools and all 7 Hospital Authority clusters on thyroid eye disease (TED), IgG4-related ophthalmic disease (IgG4ROD), and orbito-cranio-facial surgeries 

• President-elect, Asia Pacific Ophthalmic Plastic and Reconstructive Surgeries (APSOPRS) and Congress President, International Thyroid Eye Disease Society (ITEDS)

• Founding Director and Past President of the first ophthalmology subspecialty society

- Hong Kong Society of Ophthalmic Plastic and Reconstructive Surgeries (HKSOPRS)

• First academic in Orbital and Oculoplastic Surgeries (OOPS) in HK

• Honorary Consultant in 6 Hospital Authority (HA) hospitals

• City Lion Club Gold Medal Award, Faculty of Medicine, the CUHK 

• Pioneering “Early Detection and Treatments Reduce Severity” (EDTRS) and

“Image & Immune-guided, intelligent & integrated (I2GI2) management” in OOPS

through multidisciplinary, territory-wide and international platforms.